CTN clinical coordinating center contract type: IDIQ task order. POP: 8/14/20 - 8/13/25. Contract amount: not-to-exceed $37,500,000 contract minimum: $500,000

Ended Indefinite Delivery Contract Awarded Last action

Contract number
75N95020D00012
Awardee
Awarding agency
Task orders
14 $44,852,184 obligated

Award facts

Opportunity
Combined order value
$44,852,184 Current and potential, with all options
Last date to order 100% complete
IDV ceiling 97% used
$46,010,453.00
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Negotiated Proposal / Quote
Pricing
Order Dependent (IDV only)
Legislative mandates

Award details come from SAM.gov/FPDS.

About this IDV

Written by GovTribe AI ·

The National Institute on Drug Abuse awarded a single-award indefinite-delivery contract to The Emmes Company, LLC on August 14, 2020, with a ceiling value of $46,010,453 for a period of performance from August 14, 2020 through August 13, 2025. The contract carries a $500,000 minimum guarantee.

Place of performance is Rockville, Maryland. The originating solicitation, posted in November 2019, sought clinical coordinating center support services for the National Drug Abuse Treatment Clinical Trials Network, including regulatory support, quality assurance, training, pharmaceutical services, drug testing, and protocol development to support up to 36 simultaneous clinical studies with 40 study sites each, under NAICS code 541715.

Task orders issued under this IDIQ have supported NIDA's Clinical Trials Network, including the HEAL (Helping to End Addiction Long-term) initiative targeting opioid use disorder, polysubstance use, and related conditions. Recent delivery orders span multiple fiscal years: a $5,989,270 order (May 2023–May 2024) for general Clinical Coordinating Center operations; a $2,026,076 order (February–August 2024) supporting HEAL studies; a $1,063,442 order (May–August 2024) for CTN clinical coordinating center work; a $1,036,687 order (August 2023–August 2027) for a buprenorphine induction study; and a $990,350 order (September 2023–December 2027) for opioid and polysubstance use management in primary care. Earlier orders dating to August 2020 have concluded. The contract is cost-plus-fixed-fee across all visible task orders and carries no set-aside designation.

Task orders

Task order Ordering agency Obligated Awarded
FY24. Task order 14. CTN clinical coordinating center, POP: 5/15/2024-8/25/2024 75N95024F00002 National Institute on Drug Abuse (NIH) $1,063,442
To provide BIO-medical and behavioral research resources and clinical research coordinating services to support the… 75N95024F00001 National Institute on Drug Abuse (NIH) $2,026,076
FY23. CTN clinical coordinating center task order 12. September 15, 2023 to september 14, 2028. 75N95023F00005 National Institute on Drug Abuse (NIH) $30,631
FY23. To 10 - CTN clinical coordinating center - CTN-0144. Period of performance: september 7, 2023, to december 31… 75N95023F00003 National Institute on Drug Abuse (NIH) $990,350
FY23. To 11 - CTN-0145: standard versus high dose ED-initiated buprenorphine induction. POP: 8/28/23 - 8/27/24. 75N95023F00004 National Institute on Drug Abuse (NIH) $1,036,687
CTN clinical coordinating center task order 9. POP 5/15/23 - 5/14/24. 75N95023F00002 National Institute on Drug Abuse (NIH) $5,989,270
To provide BIO-medical and behavioral research resources and clinical research coordinating services to support the… 75N95023F00001 National Institute on Drug Abuse (NIH) $4,951,204
Management of unhealthy opioid and polysubstance use among patients in primary care settings. FY22. POP 9/15/22… 75N95022F00003 National Institute on Drug Abuse (NIH) $1,299,926
Clinical trials network clinical coordinating center. July 6, 2022 - july 5, 2023. Task order 6 75N95022F00002 National Institute on Drug Abuse (NIH) $4,683,571
To provide BIO-medical and behavioral research resources and clinical research coordinating services to support the… 75N95022F00001 National Institute on Drug Abuse (NIH) $6,799,700
FY21. To award task order 04, CTN clinical coordinating center.8/14/21-8/13/22 75N95021F00002 National Institute on Drug Abuse (NIH) $4,177,955
To provide BIO-medical and behavioral research resources and clinical research coordinating services to support the… 75N95021F00001 National Institute on Drug Abuse (NIH) $5,120,312
CTN clinical coordinating center support POP 08/14/20-08/13/21 75N95020F00001 National Institute on Drug Abuse (NIH) $3,744,212
CTN clinical coordinating center - heal studies. POP: 8/14/20-2/13/21 75N95020F00002 National Institute on Drug Abuse (NIH) $2,938,848
Show all 14

Transactions

Action Obligated Date
Other Administrative Action P00007 · CTN clinical coordinating center $0
Other Administrative Action P00006 $0
Other Administrative Action P00005 $0
Change Order P00004 $0
Other Administrative Action P00003 $0
Other Administrative Action P00002 $0
Other Administrative Action P00001 $0
Original award $0

Quick answers

Who was awarded contract 75N95020D00012?

75N95020D00012 was awarded to The Emmes Company, LLC by National Institute on Drug Abuse (National Institutes of Health) on August 14, 2020.

How much is contract 75N95020D00012 worth?

Orders under 75N95020D00012 have obligated $44,852,184. 75N95020D00012's own ceiling is $46,010,453.

How many orders have been placed under contract 75N95020D00012?

14 orders have been placed under 75N95020D00012, the latest on May 15, 2024.

Who can order from contract 75N95020D00012?

75N95020D00012 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract 75N95020D00012 competed?

The extent of competition for 75N95020D00012 was full and open competition. The government received 2 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV
Try for free Login